A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Shanghai Henlius Biotech
Related studies linked through entity extraction aliases.
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.
- Status
- RECRUITING
- Phase
- PHASE2
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Safety, Pharmacokinetics, and Immunogenicity of HLX6018 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized, Single Intravenous Dose, Parallel Phase I Clinical Study to Compare the Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX05 Vs. Erbitux® (Cetuximab) in Healthy Adult Male Chinese Subjects
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of HLX42 in Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Mass Balance Study of [14C]HLX208 in China Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX51 in Patients With Solid Tumor or Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Real-world Study Evaluating the Efficacy and Safety of Azvudine in Nursing Home Patients
- Status
- UNKNOWN
- Phase
- N/A
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients with MCRC
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation
- Status
- UNKNOWN
- Phase
- PHASE2